Photodynamic Therapy for Cancer Treatment – Review Article by Nature

June 20, 2024 by Modulight Content
No comments
 Modulight Corp., a leader in innovative laser solutions, is proud to announce a significant contribution to the field of cancer treatment through the publication of a comprehensive review on Photodynamic Therapy (PDT) in Nature Reviews Bioengineering. This review article, co-authored by Modulight’s CTO Dr. Petteri Uusimaa, alongside several other leading experts, highlights the transformative potential of PDT in cancer treatment, priming, and imaging. The review article, titled “Engineering Photodynamics for Treatment, Priming, and Imaging”, explores the advanced applications of PDT, a photochemistry-based treatment approach that Continue reading →

ML6600 Multiwavelength Distributed Bragg Reflector Laser Platform for Quantum Applications

May 6, 2024 by Modulight Content
No comments
Modulight ML6600 Distributed Bragg Reflector laser cores are available at various wavelengths – 650 nm, 760 nm, 780 nm, 785 nm, 795 nm, and 935 nm – relevant to quantum and spectroscopy applications. The fully in-house manufactured laser diodes exhibit reliable high-power operation with down to below 500 kHz linewidth. Designed for highest-quality mechanical, optical and acoustical isolation, and integrated with ML6600 platform’s ultra-low-noise current drivers and accurate temperature controllers, these laser cores show top-notch performance. Both free-space output and single-mode polarization maintaining fiber are Continue reading →Modulight ML6600 Distributed Bragg Reflector laser cores are available at various wavelengths - 650 nm, 760 nm, 780 nm, 785 nm, 795 nm, and 935 nm - relevant to quantum and spectroscopy applications. The fully in-house manufactured laser diodes exhibit reliable high-power operation with down to below 500 kHz linewidth. Designed for highest-quality mechanical, optical and acoustical isolation, and integrated with ML6600 platform’s ultra-low-noise current drivers and accurate temperature controllers, these laser cores show top-notch performance. Both free-space output and single-mode polarization maintaining fiber are Continue reading →

ML6600 Narrow linewidth VECSEL for photoionization of Ba for trapped ion computing

May 6, 2024 by Modulight Content
No comments
Modulight’s in-house vertical-external-cavity surface-emitting laser (VECSEL) technology integration into ML6600 laser cores paves the way for Barium trapped ion applications at wavelengths 493 nm, 532 nm and 553 nm, featuring free-running linewidth of <100 kHz with Watt-level emission. Linewidth can be further narrowed using linewidth narrowing techniques such as Pound-Drever Hall method and a stable reference. Modulight ML6600 VECSEL laser platform offers scalable and tunable high-power single-frequency emission pumped by inexpensive multimode lasers. VECSELs possess several advantages as a narrow linewidth laser platform. The external Continue reading →Modulight’s in-house vertical-external-cavity surface-emitting laser (VECSEL) technology integration into ML6600 laser cores paves the way for Barium trapped ion applications at wavelengths 493 nm, 532 nm and 553 nm, featuring free-running linewidth of <100 kHz with Watt-level emission. Linewidth can be further narrowed using linewidth narrowing techniques such as Pound-Drever Hall method and a stable reference. Modulight ML6600 VECSEL laser platform offers scalable and tunable high-power single-frequency emission pumped by inexpensive multimode lasers. VECSELs possess several advantages as a narrow linewidth laser platform. The external Continue reading →

ISO 27001 – information security standard for Modulight

February 28, 2024 by Modulight Content
No comments
Modulight achieved the international ISO 27001 information security standard certification today on February 28, 2024. The certification of the information security management system demonstrates the organization’s commitment to protecting information and managing high-level of information security. “We are expanding the use of cloud services in accordance with our SaaS business model and are making strong progress in transitioning to a pay-per-treatment (PPT) payment model. Managing patient information requires very high-level information security processes, which is why we started to pursue the ISO 27001 certification in Continue reading →Modulight achieved the international ISO 27001 information security standard certification today on February 28, 2024. The certification of the information security management system demonstrates the organization's commitment to protecting information and managing high-level of information security. "We are expanding the use of cloud services in accordance with our SaaS business model and are making strong progress in transitioning to a pay-per-treatment (PPT) payment model. Managing patient information requires very high-level information security processes, which is why we started to pursue the ISO 27001 certification in Continue reading →

Modulight Announces Involvement in GlioLighT Project for Glioma Treatment

February 14, 2024 by Modulight Content
No comments
Modulight is pleased to announce its participation in the GlioLighT project, aimed at developing new treatment options for gliomas. This project has received substantial funding of approximately EUR 2.2 million over three years from the European Innovation Council’s Pathfinder program. The GlioLighT project partners include Johannes Gutenberg University Mainz, Aston University in Birmingham, the University of Barcelona, LMU Munich, and MODUS Research and Innovation Ltd. The budgetary allotment of the project for Modulight is about EUR 400,000 over the duration of the project. Gliomas, known Continue reading →Modulight is pleased to announce its participation in the GlioLighT project, aimed at developing new treatment options for gliomas. This project has received substantial funding of approximately EUR 2.2 million over three years from the European Innovation Council's Pathfinder program. The GlioLighT project partners include Johannes Gutenberg University Mainz, Aston University in Birmingham, the University of Barcelona, LMU Munich, and MODUS Research and Innovation Ltd. The budgetary allotment of the project for Modulight is about EUR 400,000 over the duration of the project. Gliomas, known Continue reading →

Modulight Forges Strategic Partnership with Laser 2000 UK for Market Expansion in the UK and Ireland

February 9, 2024 by Modulight Content
No comments
Modulight is pleased to announce a sales partnership with Laser 2000 UK Ltd, a renowned reseller of laser-based solutions in the UK and Ireland. The partnership marks a significant step in expanding Modulight’s presence in the UK and Irish markets, leveraging Laser 2000 UK’s established customer base, broad sales team, and technical expertise. Under this collaboration, Laser 2000 UK will integrate Modulight’s cutting-edge laser technologies into their diverse range of photonics solutions. This synergy is expected to enrich Laser 2000 UK’s system solutions offering, particularly Continue reading →Modulight is pleased to announce a sales partnership with Laser 2000 UK Ltd, a renowned reseller of laser-based solutions in the UK and Ireland. The partnership marks a significant step in expanding Modulight's presence in the UK and Irish markets, leveraging Laser 2000 UK's established customer base, broad sales team, and technical expertise. Under this collaboration, Laser 2000 UK will integrate Modulight's cutting-edge laser technologies into their diverse range of photonics solutions. This synergy is expected to enrich Laser 2000 UK's system solutions offering, particularly Continue reading →

Modulight launches ML6600 for Flow Cytometry and Quantum Computing

January 14, 2024 by Modulight Content
No comments
Next week at Photonics West 2024, Modulight will unveil significant new additions to the ML6600 laser solution platform. These new innovations include a specialized laser engine tailored for Flow Cytometry applications, and advanced DBR laser cores designed specifically for the Quantum Computing market. Our #LaserFamily are presenting 11 conference papers plus participating in a technical panel, across the Photonics West conferences BIOS, OPTO, LASE and QUANTUM WEST. You can see the list here. ML6600 for Flow Cytometry – Laser engine with active beam steering The newest product utilizing the ML6600 platform is a specialized laser engine for the Continue reading →Next week at Photonics West 2024, Modulight will unveil significant new additions to the ML6600 laser solution platform. These new innovations include a specialized laser engine tailored for Flow Cytometry applications, and advanced DBR laser cores designed specifically for the Quantum Computing market. Our #LaserFamily are presenting 11 conference papers plus participating in a technical panel, across the Photonics West conferences BIOS, OPTO, LASE and QUANTUM WEST. You can see the list here. ML6600 for Flow Cytometry – Laser engine with active beam steering The newest product utilizing the ML6600 platform is a specialized laser engine for the Continue reading →

Pioneering study confirms benefits of Modulight’s technology and photoimmunotherapy for ovarian cancer

September 6, 2023 by Modulight Content
No comments
A study published in Science Advances has for the first time scientifically demonstrated the potential of fluorescence-guided photoimmunotherapy enabled with Modulight’s laser platform and cloud technology. The study, a collaboration between the University of Maryland (UMD) and Modulight, confirms the benefits of targeted nanomedicine, Modulight’s medical laser system, and fluorescence-guided intervention in both achieving better treatment outcomes and predicting tumor response. “We have already published over a hundred scientific articles on our website from world-leading research groups that have used Modulight products in their studies. This Continue reading →A study published in Science Advances has for the first time scientifically demonstrated the potential of fluorescence-guided photoimmunotherapy enabled with Modulight's laser platform and cloud technology. The study, a collaboration between the University of Maryland (UMD) and Modulight, confirms the benefits of targeted nanomedicine, Modulight’s medical laser system, and fluorescence-guided intervention in both achieving better treatment outcomes and predicting tumor response. "We have already published over a hundred scientific articles on our website from world-leading research groups that have used Modulight products in their studies. This Continue reading →

World Congress organized by Modulight and the International Photodynamic Association brings world leading experts in Photodynamic therapy to Tampere

July 10, 2023 by Modulight Content
No comments
During this week, Tampere Hall will be filled with experts and scientists in photodynamic therapy as the international congress organized by Modulight gets underway. The biennial congress, the scientific content of which are carefully screened by the International Photodynamic Association (IPA), will give medical researchers, and doctors the opportunity to share their ideas, research results and new discoveries in the field of medicine and technology. The congress, which starts on Monday 10 July, will be opened by Anna-Kaisa Ikonen, Minister of Local Government of Finland, Continue reading →During this week, Tampere Hall will be filled with experts and scientists in photodynamic therapy as the international congress organized by Modulight gets underway. The biennial congress, the scientific content of which are carefully screened by the International Photodynamic Association (IPA), will give medical researchers, and doctors the opportunity to share their ideas, research results and new discoveries in the field of medicine and technology. The congress, which starts on Monday 10 July, will be opened by Anna-Kaisa Ikonen, Minister of Local Government of Finland, Continue reading →

Bausch + Lomb and Modulight Announce FDA Approval of ML6710i Photodynamic Laser for Use with Bausch + Lombs VISUDYNE (Verteporfin for Injection)

February 1, 2023 by Ulla Haapanen
No comments
Bausch + Lomb and Modulight Announce FDA Approval of ML6710i Photodynamic Laser for Use with Bausch + Lomb’s VISUDYNE® (Verteporfin for Injection) VAUGHAN, Ontario and TAMPERE, Finland, Feb. 1, 2023 – Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, and Modulight Corporation (“Modulight”), a biomedical laser company, today announced that the U.S. Food and Drug Administration (FDA) has approved the ML6710i photodynamic laser for equivalent use with Bausch + Lomb’s VISUDYNE® (verteporfin for injection) photodynamic therapy (PDT) for the treatment Continue reading →Modulight Investor Contacts: Ulla Haapanen ulla.haapanen@modulight.com (408) 218-7960 Modulight Media Contacts: Zoe Ylöniemi zoe.yloniemi@modulight.com (408) 239-3488 Bausch + Lomb Investor Contacts: Arthur Shannon/Allison Ryan arthur.shannon@bausch.com allison.ryan@bausch.com (877) 354-3705 (toll free); (908) 927-0735 Bausch + Lomb Media Contacts: Lainie Keller/Kristy Marks lainie.keller@bausch.com kristy.marks@bausch.com (908) 927-1198; (908) 927-0683 Bausch + Lomb and Modulight Announce FDA Approval of ML6710i Photodynamic Laser for Use with Bausch + Lomb’s VISUDYNE® (Verteporfin for Injection) VAUGHAN, Ontario and TAMPERE, Finland, Feb. 1, 2023 – Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global Continue reading →